ENDPOINTS

Genfit's up to €185M royalty deal; J&J’s Tremfya gets a Crohn's approval

Mar 21, 2025 - 19:42
 0
Genfit's up to €185M royalty deal; J&J’s Tremfya gets a Crohn's approval
Read More

Tags:

Previous Article

Google releases new AI models for drug discovery

Next Article

Blue Ghost Watches the Lunar Sunset, Signalling the End of its Mission

Related Posts

Jeb Keiper steps down from Nimbus CEO post, business chief to take over

Jeb Keiper steps down from Nimbus CEO post, business ch...

Mar 7, 2025  0

Tune’s CEO search ends as John McHutchison takes top spot; More from Pfizer’s leadership makeover

Tune’s CEO search ends as John McHutchison takes top sp...

Mar 7, 2025  0

Moderna earnings: Losses narrow as biotech cuts costs

Moderna earnings: Losses narrow as biotech cuts costs

Feb 14, 2025  0